Stock listing

TPEx:4147 TaiMed Biologics Inc. (中裕) 股價

Follow TaiMed Biologics Inc. into a list and get an email when it puts out news.

Share price · TPEX:4147

$59.50 TWD -0.90 (-1.5%)

Close on Oct 15, 2026

TaiMed Biologics Inc. logo
Ticker
TPEx:4147
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Latest news

TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan

Jul 7, 2026

TaiMed Biologics Completes Phase 2b Enrollment for TMB-365/380 in HIV Maintenance Therapy Study

May 21, 2026

First Patient Enrolled in the Study Evaluating Bi-monthly and Quarterly Dosing of the Long-Acting TMB-365/TMB-380 mAb Combination Maintenance Therapy

Jul 28, 2022

Important Resolutions of the Company's 2022 General Shareholders' Meeting

May 30, 2022

Announcement of members of the Company's Compensation Committee

May 30, 2022

Announcement of members of the Company's 3rd Audit Committee

May 30, 2022

2022 general shareholders' meeting approved the lifting of non-competition restrictions for directors

May 30, 2022

Announcement of the Company's list of newly elected directors and independent directors

May 30, 2022

Announcement of Change of Board of Directors Chairperson

May 30, 2022

TaiMed Biologics received the official approval letter from US FDA for the pre-approval inspection (PAI) of cGMP monoclonal antibody facility

May 26, 2022

All TaiMed Biologics Inc. news

TaiMed Biologics Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 19 in all · newest Jul 7, 2026 · oldest 2022

Log in to ask 6ix AI your own questions about TaiMed Biologics Inc.